http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7be8902e45d276838b872b0089112106
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Tutt |
| name | Andrew Tutt |
| given-name | Andrew |
| organization-name | 3Oncology Unit, Guy's and St. Thomas NHS Foundation Trust, 1The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.; 5Breast Cancer Now Research Unit, King's College London, London, United Kingdom. 5King's College London, London, United Kingdom.; 6Institute of Cancer Research, London, United Kingdom. Breakthrough Breast Cancer Research Unit, Guy’s Hospital, London SE19RT, UK.; Department of Research Oncology, King’s College London, London SE19RT, UK. 1Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. Otto Metzger-Filho, Evandro de Azambuja, Kamal S. Saini, Sherene Loi, Hatem A. Azim Jr, Christos Sotiriou, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Andrew Tutt and Paul Ellis, King's College London, Guy's Campus, London; Judith M. Bliss, Institute of Cancer Research, Sutton; Ian Bradbury, Frontier Science, Kincraig, Scotland, United Kingdom; Giuseppe Viale, European Institute of Oncology, University of Milan, Milan; Angelo Di Leo, Hospital of... Authors' Affiliations: 1Breast Cancer Biology, King's College London, Guy's Hospital; 2Membrane/Cytoskeleton Signalling Group, Cardiovascular Division, James Black Centre, King's College London; 3Breakthrough Breast Cancer Research Unit, King's College London, Guy's Hospital; 4Breast Research Pathology, Research Oncology, King's College London, Guy's Hospital, London, United Kingdom; and 5Consortium for Functional Glycomics, The Scripps Research Institute, La Jolla, California 3Oncology Unit, Guy's and St. Thomas NHS Foundation Trust; Authors' Affiliations: 1Stem Cell Group, 2Breakthrough Breast Cancer Research Unit, 3Research Oncology, King's College London School of Medicine, Guy's Hospital; 4Department of Craniofacial Development and Stem Cell Biology, King's College London, Guy's Hospital; 5Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, London, United Kingdom; and 6Rutgers New Jersey Medical School, Newark, New Jersey; Authors' Affiliations: 1Stem Cell Group, 2Breakthrough Breast Cancer Research Unit, 3Research Oncology, King's College London School of Medicine, Guy's Hospital; 4Department of Craniofacial Development and Stem Cell Biology, King's College London, Guy's Hospital; 5Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, London, United Kingdom; and 6Rutgers New Jersey Medical School, Newark, New Jersey Authors' Affiliations: 1Univ. Lille Nord de France; 2Université des Sciences et Technologies de Lille, Unité de Glycobiologie Structurale et Fonctionnelle; 3Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576; 4Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8161, Institut de Biologie de Lille-Institut Pasteur de Lille, Lille, France; 5Institut National de la Santé et de la Recherche Médicale U908, Villeneuve d'Ascq, France; and 6Breast Cancer Biology Group and 7Breakthrough Breast Cancer Research Unit, Guy's Hospital, King's Health Partners Academic Health Sciences Centre, London, United Kingdom Breast Cancer Now Research Unit, Innovation Hub, Cancer Centre at Guy's Hospital, Faculty of Life Sciences and Medicine, King's College London London UK; School of Cancer and Pharmaceutical Sciences CRUK King's Health Partners Centre, King's College London, Innovation Hub, Cancer Centre at Guy's Hospital, Great Maze Pond London UK; Breast Cancer Now, The Institute of Cancer Research London UK Breakthrough Breast Cancer Research Unit, Research Oncology, King’s College London, Guy’s Hospital, London SE1 9RT, UK. 1The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; Authors' Affiliations: 1The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; 2Breast Unit, Royal Marsden Hospital; 3Breakthrough Breast Cancer Research Unit, King's College London School of Medicine, Guy's Hospital, London, United Kingdom 3Breast Cancer Now Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom. From the Drug Development Unit, Royal Marsden National Health Service Foundation Trust; The Institute of Cancer Research, Sutton, Surrey; Institute of Genetics and Molecular Medicine, University of Edinburgh Cancer Research, Edinburgh; the Breakthrough Breast Cancer Research Unit at King's College London, Guy's Campus; the Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London; AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom; the Netherlands Cancer... Authors' Affiliations: 1Breast Cancer Center, Medical Oncology Department, University Hospital Vall d'Hebron, Barcelona, Spain; 2Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; 3Guy's Hospital, Integrated Cancer Centre, Kings Health Partners, Academic Health Sciences Centre, London, United Kingdom; and 4Dana-Farber Cancer Institute, Boston, Massachusetts Consultant Clinical Oncologist/Director, Breakthrough Breast Cancer Research Unit, Guy’s Hospital, King’s Health Partners AHSC, London, UK. Guy's Hospital, King's Health Partners Academic Health Sciences Centre, London, United Kingdom Breast Cancer Now Research Unit, Division of Cancer Studies, Guy’s Hospital, King’s College London School of Medicine, London SE1 9RT, UK; Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK Breast Cancer Now Research Unit, King’s College London, London SE1 9RT, United Kingdom;; Division of Cancer Studies, King’s Health Partners Academic Health Science Centre, Faculty of Life Sciences and Medicine, King’s College London, London SE1 9RT, United Kingdom;; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, United Kingdom |
Incoming Links
Total number of triples: 162.